Literature DB >> 8740301

Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender. Arbeitsgemeinschaft für Pädiatrische, Nephrologie.

K Zerres1, S Rudnik-Schöneborn, F Deget, U Holtkamp, J Brodehl, J Geisert, K Schärer.   

Abstract

The clinical course of 66 boys and 49 girls with autosomal recessive polycystic kidney disease recruited from departments of paediatric nephrology was investigated over a mean observation period of 4.92 years. This is a selected study group of children from departments of paediatric nephrology who in most cases survived the neonatal period, since birth clinics did not participate. The median age at diagnosis was 29 days (prenatal to 14.5 years). We observed decreased glomerular filtration rates (GFRs) in 72% (median age at onset of decrease of GFR < 2 SD, 0.6 years; range, 0-18.7 years), and 11 patients developed end-stage renal disease. Hypertension requiring drug treatment was found in 70% (median age at start of medication, 0.5 years; range, 0-16.7 years). Kidney length was above the 97th centile in 68% of patients, and kidney length did not increase with age or deterioration of renal function. Urinary tract infections occurred in 30%, growth retardation in 25%, and clinical signs of hepatic fibrosis were detected in 46%. Thirteen patients (11%) died during the observation period, 10 of them in the first year of life. There was a statistically significant sex difference in terms of a more pronounced progression in girls. The survival probability at 1 year was 94% for male patients and 82% for female patients (p < 0.05) in this study. Urinary tract infections occurred more frequently in girls (p < 0.025) and were observed earlier. In addition, more girls had impaired renal function, developed end-stage renal disease and showed growth retardation; these differences, however, were not significant. For the children in this study, however, our results indicate that the long-term prognosis in the majority of cases is better throughout childhood and youth than often stated.

Entities:  

Mesh:

Year:  1996        PMID: 8740301     DOI: 10.1111/j.1651-2227.1996.tb14056.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  40 in total

1.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta.

Authors:  M Moser; A Pscherer; C Roth; J Becker; G Mücher; K Zerres; C Dixkens; J Weis; L Guay-Woodford; R Buettner; R Fässler
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

2.  Autosomal recessive polycystic kidney disease: improvement of renal function.

Authors:  Bettina M Bosch; Christian Plank; Wolfgang Rascher; Jörg Dötsch
Journal:  Eur J Pediatr       Date:  2003-03-22       Impact factor: 3.183

3.  Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney disease.

Authors:  Meral Gunay-Aygun; Baris I Turkbey; Joy Bryant; Kailash T Daryanani; Maya Tuchman Gerstein; Katie Piwnica-Worms; Peter Choyke; Theo Heller; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-09-08       Impact factor: 4.797

4.  Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.

Authors:  Meral Gunay-Aygun; Ellis D Avner; Robert L Bacallao; Peter L Choyke; Joseph T Flynn; Gregory G Germino; Lisa Guay-Woodford; Peter Harris; Theo Heller; Julie Ingelfinger; Frederick Kaskel; Robert Kleta; Nicholas F LaRusso; Parvathi Mohan; Gregory J Pazour; Benjamin L Shneider; Vicente E Torres; Patricia Wilson; Colleen Zak; Jing Zhou; William A Gahl
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

Review 5.  Diagnosis and management of childhood polycystic kidney disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

Review 6.  Liver and kidney disease in ciliopathies.

Authors:  Meral Gunay-Aygun
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-11-15       Impact factor: 3.908

7.  Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.

Authors:  Marusia Lilova; Bernard S Kaplan; Kevin E C Meyers
Journal:  Pediatr Nephrol       Date:  2002-11-26       Impact factor: 3.714

8.  Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway.

Authors:  Miguel A Garcia-Gonzalez; Luis F Menezes; Klaus B Piontek; Junya Kaimori; David L Huso; Terry Watnick; Luiz F Onuchic; Lisa M Guay-Woodford; Gregory G Germino
Journal:  Hum Mol Genet       Date:  2007-06-16       Impact factor: 6.150

9.  Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up.

Authors:  Wael A Seliem; Michael C Falk; Bruce Shadbolt; Alison L Kent
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

10.  Autosomal recessive polycystic kidney disease: outcomes from a single-center experience.

Authors:  Rhona Capisonda; Veronique Phan; Jeffrey Traubuci; Alan Daneman; J Williamson Balfe; Lisa M Guay-Woodford
Journal:  Pediatr Nephrol       Date:  2003-01-21       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.